88 related articles for article (PubMed ID: 21732742)
1. Nuclear MASPIN expression relates to a better prognosis in elderly patients with laryngeal carcinoma.
Marioni G; Blandamura S; Lionello M; Giacomelli L; Staffieri C; Fasanaro E; Manzato E; Staffieri A
Acta Otolaryngol; 2011 Nov; 131(11):1220-5. PubMed ID: 21732742
[TBL] [Abstract][Full Text] [Related]
2. MASPIN subcellular localization and expression in oral cavity squamous cell carcinoma.
Marioni G; Gaio E; Giacomelli L; Bertolin A; D'Alessandro E; Stramare R; Facco E; Staffieri A; Blandamura S
Eur Arch Otorhinolaryngol; 2008 Jul; 265 Suppl 1():S97-104. PubMed ID: 18236066
[TBL] [Abstract][Full Text] [Related]
3. Nuclear localization of mammary serine protease inhibitor (MASPIN): is its impact on the prognosis in laryngeal carcinoma due to a proapoptotic effect?
Marioni G; Giacomelli L; D'Alessandro E; Marchese-Ragona R; Staffieri C; Ferraro SM; Staffieri A; Blandamura S
Am J Otolaryngol; 2008; 29(3):156-62. PubMed ID: 18439947
[TBL] [Abstract][Full Text] [Related]
4. Nuclear expression of maspin is associated with a lower recurrence rate and a longer disease-free interval after surgery for squamous cell carcinoma of the larynx.
Marioni G; Blandamura S; Giacomelli L; Calgaro N; Segato P; Leo G; Fischetto D; Staffieri A; de Filippis C
Histopathology; 2005 May; 46(5):576-82. PubMed ID: 15842640
[TBL] [Abstract][Full Text] [Related]
5. Nuclear maspin expression as a good prognostic factor in human epithelial ovarian carcinoma.
Sopel M; Surowiak P; Berdowska I
Folia Morphol (Warsz); 2010 Nov; 69(4):204-12. PubMed ID: 21120806
[TBL] [Abstract][Full Text] [Related]
6. mTOR expression and prognosis in elderly patients with laryngeal carcinoma: uni- and multivariate analyses.
Marioni G; Staffieri A; Lora L; Fermo S; Giacomelli L; La Torre FB; Favaretto N; Valentini E; Manzato E; Blandamura S
Oral Oncol; 2012 Jun; 48(6):530-4. PubMed ID: 22285859
[TBL] [Abstract][Full Text] [Related]
7. A high nuclear nm23-H1 expression is associated with a better prognosis in elderly patients with laryngeal carcinoma.
Lionello M; Blandamura S; Lovato A; Franchella S; Giacomelli L; Ottaviano G; Stellini E; Staffieri A; Marioni G
Acta Otolaryngol; 2013 Aug; 133(8):874-80. PubMed ID: 23768014
[TBL] [Abstract][Full Text] [Related]
8. Postoperative radiotherapy for laryngeal carcinoma: the prognostic role of subcellular Maspin expression.
Lionello M; Blandamura S; Staffieri C; Tealdo G; Giacomelli L; Marchese Ragona R; de Filippis C; Staffieri A; Marioni G
Am J Otolaryngol; 2015; 36(2):184-9. PubMed ID: 25459315
[TBL] [Abstract][Full Text] [Related]
9. Laryngeal carcinoma lymph node metastasis and disease-free survival correlate with MASPIN nuclear expression but not with EGFR expression: a series of 108 cases.
Marioni G; Staffieri A; Bertolin A; Giacomelli L; D'Alessandro E; Ottaviano G; Accordi D; Stramare R; de Filippis C; Blandamura S
Eur Arch Otorhinolaryngol; 2010 Jul; 267(7):1103-10. PubMed ID: 20052590
[TBL] [Abstract][Full Text] [Related]
10. Loss of Maspin expression is a negative prognostic factor in common salivary gland tumors.
Schwarz S; Ettl T; Kleinsasser N; Hartmann A; Reichert TE; Driemel O
Oral Oncol; 2008 Jun; 44(6):563-70. PubMed ID: 17936671
[TBL] [Abstract][Full Text] [Related]
11. Expression of the tumour-suppressor maspin in temporal bone carcinoma.
Marioni G; Zanoletti E; Stritoni P; Lionello M; Giacomelli L; Gianatti A; Cattaneo L; Blandamura S; Mazzoni A; Martini A
Histopathology; 2013 Aug; 63(2):242-9. PubMed ID: 23730906
[TBL] [Abstract][Full Text] [Related]
12. Maspin in thyroid cancer: its relationship with p53 and clinical outcome.
Boltze C; Schneider-Stock R; Meyer F; Peters B; Quednow C; Hoang-Vu C; Roessner A
Oncol Rep; 2003; 10(6):1783-7. PubMed ID: 14534696
[TBL] [Abstract][Full Text] [Related]
13. Mammalian target of rapamycin expression and laryngeal squamous cell carcinoma prognosis: novel preliminary evidence.
Marioni G; Staffieri A; Giacomelli L; Lionello M; Guzzardo V; Busnardo A; Blandamura S
Histopathology; 2011 Jun; 58(7):1148-56. PubMed ID: 21707714
[TBL] [Abstract][Full Text] [Related]
14. Nm23-H1 nuclear expression is associated with a more favourable prognosis in laryngeal carcinoma: univariate and multivariate analysis.
Marioni G; Ottaviano G; Lionello M; Lora L; Lovato A; Staffieri C; Favaretto N; Giacomelli L; Stellini E; Staffieri A; Blandamura S
Histopathology; 2012 Dec; 61(6):1057-64. PubMed ID: 22978449
[TBL] [Abstract][Full Text] [Related]
15. Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression.
Yu M; Zheng H; Tsuneyama K; Takahashi H; Nomoto K; Xu H; Takano Y
Hum Pathol; 2007 Aug; 38(8):1248-55. PubMed ID: 17490717
[TBL] [Abstract][Full Text] [Related]
16. Expression of maspin tumor suppressor and mTOR in laryngeal carcinoma.
Marioni G; Ottaviano G; Lovato A; Franz L; Bandolin L; Contro G; Giacomelli L; Alessandrini L; Stramare R; de Filippis C; Blandamura S
Am J Otolaryngol; 2020; 41(1):102322. PubMed ID: 31732312
[TBL] [Abstract][Full Text] [Related]
17. MASPIN's prognostic role in patients with advanced head and neck carcinoma treated with primary chemotherapy (carboplatin plus vinorelbine) and radiotherapy: preliminary evidence.
Marioni G; Koussis H; Gaio E; Giacomelli L; Bertolin A; D'Alessandro E; Scola A; Ottaviano G; de Filippis C; Jirillo A; Staffieri A; Blandamura S
Acta Otolaryngol; 2009 Jul; 129(7):786-92. PubMed ID: 18819022
[TBL] [Abstract][Full Text] [Related]
18. Maspin overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human ovarian carcinoma.
Bolat F; Gumurdulu D; Erkanli S; Kayaselcuk F; Zeren H; Ali Vardar M; Kuscu E
Pathol Res Pract; 2008; 204(6):379-87. PubMed ID: 18343598
[TBL] [Abstract][Full Text] [Related]
19. Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma.
Sittel C; Eckel HE; Damm M; von Pritzbuer E; Kvasnicka HM
Laryngoscope; 2000 Jun; 110(6):1012-7. PubMed ID: 10852523
[TBL] [Abstract][Full Text] [Related]
20. Nuclear expression of onco-suppressors nm23-H1 and maspin are associated with lower recurrence rate in laryngeal carcinoma.
Marioni G; Ottaviano G; de Filippis C; Fasanaro E; Randon B; Meneghesso S; Giacomelli L; Astolfi L; Blandamura S
Am J Otolaryngol; 2019; 40(2):224-229. PubMed ID: 30683471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
